Setareh Moghimi

2.1k total citations · 1 hit paper
81 papers, 1.7k citations indexed

About

Setareh Moghimi is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Setareh Moghimi has authored 81 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Organic Chemistry, 21 papers in Pharmacology and 18 papers in Molecular Biology. Recurrent topics in Setareh Moghimi's work include Synthesis and biological activity (40 papers), Synthesis and Characterization of Heterocyclic Compounds (17 papers) and Quinazolinone synthesis and applications (16 papers). Setareh Moghimi is often cited by papers focused on Synthesis and biological activity (40 papers), Synthesis and Characterization of Heterocyclic Compounds (17 papers) and Quinazolinone synthesis and applications (16 papers). Setareh Moghimi collaborates with scholars based in Iran, Saudi Arabia and Türkiye. Setareh Moghimi's co-authors include Alireza Foroumadi, Adileh Ayati, Mohammad Mahdavi, Loghman Firoozpour, Maliheh Safavi, Somayeh Salarinejad, Majid M. Heravı, Behjat Pouramiri, Abbas Shafiee and Mahsa Toolabi and has published in prestigious journals such as Scientific Reports, Tetrahedron and Tetrahedron Letters.

In The Last Decade

Setareh Moghimi

80 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy

2020 278 citations Adileh Ayati, Setareh Moghimi et al. Bioorganic Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Setareh Moghimi Iran	22	1.3k	534	211	194	184	81	1.7k
Somaia S. Abd El‐Karim Egypt	19	922 0.7×	315 0.6×	166 0.8×	179 0.9×	163 0.9×	51	1.2k
Aniket P. Sarkate India	24	1.4k 1.1×	406 0.8×	210 1.0×	153 0.8×	149 0.8×	102	1.7k
Zhi‐Hao Shi China	24	525 0.4×	748 1.4×	339 1.6×	106 0.5×	235 1.3×	74	1.6k
Ahmed M. Alafeefy Saudi Arabia	23	1.3k 1.0×	839 1.6×	201 1.0×	124 0.6×	116 0.6×	71	1.7k
Adileh Ayati Iran	12	898 0.7×	422 0.8×	91 0.4×	127 0.7×	178 1.0×	23	1.2k
Linxiang Zhao China	21	722 0.6×	631 1.2×	99 0.5×	57 0.3×	181 1.0×	83	1.3k
Xuewei Wu China	15	463 0.4×	693 1.3×	127 0.6×	84 0.4×	212 1.2×	28	1.3k
Bahaa Elgendy United States	21	570 0.4×	508 1.0×	108 0.5×	83 0.4×	201 1.1×	62	1.4k
Kunal Nepali India	21	966 0.8×	645 1.2×	161 0.8×	71 0.4×	106 0.6×	34	1.5k
Roberta Bortolozzi Italy	28	1.4k 1.1×	798 1.5×	171 0.8×	80 0.4×	258 1.4×	74	2.1k

Countries citing papers authored by Setareh Moghimi

Since Specialization

Citations

This map shows the geographic impact of Setareh Moghimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Setareh Moghimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Setareh Moghimi more than expected).

Fields of papers citing papers by Setareh Moghimi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Setareh Moghimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Setareh Moghimi. The network helps show where Setareh Moghimi may publish in the future.

Co-authorship network of co-authors of Setareh Moghimi

This figure shows the co-authorship network connecting the top 25 collaborators of Setareh Moghimi. A scholar is included among the top collaborators of Setareh Moghimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Setareh Moghimi. Setareh Moghimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salarinejad, Somayeh, Setareh Moghimi, Mahsa Toolabi, et al.. (2024). Design, synthesis, and biological evaluation of new biaryl derivatives of cycloalkyl diacetamide bearing chalcone moiety as type II c-MET kinase inhibitors. Molecular Diversity. 28(6). 4167–4180. 1 indexed citations

Peytam, Fariba, Loghman Firoozpour, Setareh Moghimi, et al.. (2023). Imidazo[1,2-a]quinazolines as novel, potent EGFR-TK inhibitors: Design, synthesis, bioactivity evaluation, and in silico studies. Bioorganic Chemistry. 133. 106383–106383. 10 indexed citations

Firoozpour, Loghman, et al.. (2023). Design, synthesis and α-glucosidase inhibition study of novel pyridazin-based derivatives. Medicinal Chemistry Research. 32(4). 713–722. 7 indexed citations

Mousavi, Alireza, et al.. (2023). Quinazoline-based VEGFR-2 inhibitors as potential anti-angiogenic agents: A contemporary perspective of SAR and molecular docking studies. European Journal of Medicinal Chemistry. 259. 115626–115626. 41 indexed citations

Moghimi, Setareh, Fariba Peytam, Roham Foroumadi, et al.. (2022). Design, synthesis and evaluation of novel tetrahydropyridothienopyrimidin-ureas as cytotoxic and anti-angiogenic agents. Scientific Reports. 12(1). 9683–9683. 8 indexed citations

Nadri, Hamid, Setareh Moghimi, Roham Foroumadi, et al.. (2022). Novel 3-aminobenzofuran derivatives as multifunctional agents for the treatment of Alzheimer’s disease. Frontiers in Chemistry. 10. 882191–882191. 6 indexed citations

Peytam, Fariba, Setareh Moghimi, Loghman Firoozpour, et al.. (2021). Design, synthesis, molecular docking, and in vitro α-glucosidase inhibitory activities of novel 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-a]pyrimidines against yeast and rat α-glucosidase. Scientific Reports. 11(1). 11911–11911. 52 indexed citations

Ayati, Adileh, Setareh Moghimi, Mahsa Toolabi, & Alireza Foroumadi. (2021). Pyrimidine-based EGFR TK inhibitors in targeted cancer therapy. European Journal of Medicinal Chemistry. 221. 113523–113523. 83 indexed citations

Moghimi, Setareh, Somayeh Salarinejad, Mahsa Toolabi, et al.. (2021). Synthesis, in-vitro evaluation, molecular docking, and kinetic studies of pyridazine-triazole hybrid system as novel α-glucosidase inhibitors. Bioorganic Chemistry. 109. 104670–104670. 33 indexed citations

10.

Toolabi, Mahsa, Mona Khoramjouy, Adileh Ayati, et al.. (2020). Synthesis and radioligand‐binding assay of 2,5‐disubstituted thiadiazoles and evaluation of their anticonvulsant activities. Archiv der Pharmazie. 353(12). e2000066–e2000066. 12 indexed citations

11.

Ayati, Adileh, Setareh Moghimi, Somayeh Salarinejad, et al.. (2020). A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy. Bioorganic Chemistry. 99. 103811–103811. 278 indexed citations breakdown →

12.

Toolabi, Mahsa, et al.. (2019). 2-(Bipiperidin-1-yl)-5-(nitroaryl)-1,3,4-thiadiazoles: Synthesis, evaluation of in vitro leishmanicidal activity, and mechanism of action. Bioorganic & Medicinal Chemistry. 27(16). 3682–3691. 13 indexed citations

13.

Toolabi, Mahsa, Setareh Moghimi, Somayeh Salarinejad, et al.. (2019). 6-Cinnamoyl-4-arylaminothienopyrimidines as highly potent cytotoxic agents: Design, synthesis and structure-activity relationship studies. European Journal of Medicinal Chemistry. 185. 111786–111786. 39 indexed citations

14.

Heidary, Hossein, et al.. (2018). Spectroscopic and Molecular Docking Studies on DNA Binding Interaction of Podophyllotoxin. Journal of sciences, Islamic Republic of Iran. 29(2). 121–127. 5 indexed citations

15.

Firoozpour, Loghman, et al.. (2018). Synthesis and Biological Evaluation of 2-Phenyl Benzothiazole Derivatives as Cytotoxic Agents. Journal of sciences, Islamic Republic of Iran. 29(4). 335–340. 2 indexed citations

16.

Ayati, Adileh, Rezvan Esmaeili, Setareh Moghimi, et al.. (2018). Synthesis and biological evaluation of 4-amino-5-cinnamoylthiazoles as chalcone-like anticancer agents. European Journal of Medicinal Chemistry. 145. 404–412. 39 indexed citations

17.

Ayati, Adileh, Setareh Moghimi, Rezvan Esmaeili, et al.. (2018). Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety. European Journal of Medicinal Chemistry. 155. 483–491. 41 indexed citations

18.

Shariatifar, Nabi, Mohammad Rezaei, Mehran Sayadi, et al.. (2016). In-vitro Antibacterial Evaluation of Some Fluoroquinolone Derivatives Against Food Borne Bacteria. Journal of sciences, Islamic Republic of Iran. 27(2). 129–133. 2 indexed citations

19.

Sayahi, Mohammad Hosein, Setareh Moghimi, Mohammad Mahdavi, et al.. (2016). An Efficient Four-Step Approach Toward Fused Triazino[1,6-a] Quinazolines. Combinatorial Chemistry & High Throughput Screening. 19(3). 189–192. 1 indexed citations

20.

Mahdavi, Mohammad, et al.. (2015). Combined isocyanide-based multi-component Ullmann-type reaction: an efficient access to novel nitrogen-containing pentacyclic compounds. Molecular Diversity. 19(4). 797–805. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact